{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:27:51Z","timestamp":1781634471311,"version":"3.54.5"},"reference-count":157,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-17-0090"],"award-info":[{"award-number":["APVV-17-0090"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Research on the neurobiology of cancer, which lies at the border of neuroscience and oncology, has elucidated the mechanisms and pathways that enable the nervous system to modulate processes associated with cancer initiation and progression. This research has also shown that several drugs which modulate interactions between the nervous system and the tumor micro- and macroenvironments significantly reduced the progression of cancer in animal models. Encouraging results were also provided by prospective clinical trials investigating the effect of drugs that reduce adrenergic signaling on the course of cancer in oncological patients. Moreover, it has been shown that reducing adrenergic signaling might also reduce the incidence of cancer in animal models, as well as in humans. However, even if many experimental and clinical findings have confirmed the preventive and therapeutic potential of drugs that reduce the stimulatory effect of the nervous system on processes related to cancer initiation and progression, several questions remain unanswered. Therefore, the aim of this review is to critically evaluate the efficiency of these drugs and to discuss questions that need to be answered before their introduction into conventional cancer treatment and prevention.<\/jats:p>","DOI":"10.3390\/ijms22116115","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T23:59:55Z","timestamp":1623023995000},"page":"6115","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-6819","authenticated-orcid":false,"given":"Boris","family":"Mravec","sequence":"first","affiliation":[{"name":"Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia"},{"name":"Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, 845 05 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semcancer.2007.12.002","article-title":"Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain","volume":"18","author":"Mravec","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: Beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrn2647","article-title":"Neural regulation of endocrine and autonomic stress responses","volume":"10","author":"Herman","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_5","first-page":"S17","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2017\/18: G protein-coupled receptors","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mravec, B., Horvathova, L., and Hunakova, L. (2020). Neurobiology of cancer: The role of \u03b2-adrenergic receptor signaling in various tumor environments. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217958"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/0008-5472.CAN-16-1701","article-title":"Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction","volume":"78","author":"Allen","year":"2018","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.18632\/oncotarget.2652","article-title":"Norepinephrine promotes tumor microenvironment reactivity through beta3-adrenoreceptors during melanoma progression","volume":"6","author":"Calvani","year":"2015","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.psyneuen.2014.10.004","article-title":"alpha2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression","volume":"51","author":"Lamkin","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Calvani, M., Bruno, G., Dabraio, A., Subbiani, A., Bianchini, F., Fontani, F., Casazza, G., Vignoli, M., De Logu, F., and Frenos, S. (2020). beta3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041420"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Florent, R., Poulain, L., and N\u2019Diaye, M. (2020). Drug Repositioning of the alpha1-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155339"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4149\/neo_2020_200422N432","article-title":"Norepinephrine release may play a critical role in the Warburg effect: An integrative model of tumorigenesis","volume":"67","author":"Fitzgerald","year":"2020","journal-title":"Neoplasma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/bjc.2015.133","article-title":"Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage","volume":"112","author":"Reeder","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature10368","article-title":"A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1","volume":"477","author":"Hara","year":"2011","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/cc.23368","article-title":"Pharmacological blockade of a beta(2)AR-beta-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model","volume":"12","author":"Hara","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15950","DOI":"10.1038\/srep15950","article-title":"Adrenergic DNA damage of embryonic pluripotent cells via beta2 receptor signalling","volume":"5","author":"Sun","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ncomms2413","article-title":"Src activation by beta-adrenoreceptors is a key switch for tumour metastasis","volume":"4","author":"Allen","year":"2013","journal-title":"Nat. Commun"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-010-0822-2","article-title":"The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells","volume":"125","author":"Shi","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1158\/1078-0432.CCR-09-0585","article-title":"Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines","volume":"15","author":"Gu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1078\/1438-4639-00187","article-title":"DNA damage in a human population affected by chronic psychogenic stress","volume":"206","author":"Dimitroglou","year":"2003","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1667\/RR15193.1","article-title":"Adrenergic Receptor Signaling Regulates the Response of Tumors to Ionizing Radiation","volume":"191","author":"MacDonald","year":"2019","journal-title":"Radiat. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","article-title":"beta2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer","volume":"33","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2016.08.016","article-title":"Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells","volume":"59","author":"Huan","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/carcin\/10.9.1753","article-title":"Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line","volume":"10","author":"Schuller","year":"1989","journal-title":"Carcinogenesis"},{"key":"ref_26","first-page":"889","article-title":"Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38\/MAPK pathway","volume":"59","author":"Huang","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4149\/neo_2011_05_424","article-title":"Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats","volume":"58","author":"Lackovicova","year":"2011","journal-title":"Neoplasma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41389-018-0090-2","article-title":"beta2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent\/metastatic HPV(+) HNSCC","volume":"7","author":"Lucido","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/ijc.25589","article-title":"Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism","volume":"128","author":"Park","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","article-title":"Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression","volume":"23","author":"Yang","year":"2009","journal-title":"Brain. Behav. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/onc.2016.319","article-title":"Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1","volume":"36","author":"Hulsurkar","year":"2017","journal-title":"Oncogene"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","article-title":"Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1242\/jcs.194803","article-title":"Cancer cells become less deformable and more invasive with activation of beta-adrenergic signaling","volume":"129","author":"Kim","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_35","first-page":"2866","article-title":"Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers","volume":"61","author":"Masur","year":"2001","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3109\/13880209.2014.892513","article-title":"beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration","volume":"52","author":"Iseri","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41419-019-2030-2","article-title":"Chronic stress promotes gastric cancer progression and metastasis: An essential role for ADRB2","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/1568009617666170330151415","article-title":"The beta 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line","volume":"17","author":"Rivero","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2021.01.029","article-title":"Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients","volume":"147","author":"Gillis","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_41","unstructured":"Katzung, B. (2017). Antihypertensive Agents. Basic & Clinical Pharmacology, McGraw-Hill. [14th ed.]."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.podrm.2017.02.006","article-title":"Propranolol","volume":"42","author":"Bakheit","year":"2017","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","article-title":"Propranolol Reduces Cancer Risk: A Population-Based Cohort Study","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltim. )"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","article-title":"Impact of beta blockers on epithelial ovarian cancer survival","volume":"127","author":"Diaz","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2013.01.007","article-title":"Association between use of beta-blockers and prostate cancer-specific survival: A cohort study of 3561 prostate cancer patients with high-risk or metastatic disease","volume":"65","author":"Grytli","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","article-title":"beta-Blockers and survival among Danish patients with malignant melanoma: A population-based cohort study","volume":"20","author":"Lemeshow","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3802\/jgo.2018.29.e82","article-title":"Impact of beta blockers on survival outcomes in ovarian cancer: A nationwide population-based cohort study","volume":"29","author":"Baek","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/annonc\/mdx264","article-title":"Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: A retrospective analysis of the ROSE\/TRIO-012 study","volume":"28","author":"Spera","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1158\/0008-5472.CAN-17-0108","article-title":"Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma","volume":"77","author":"Udumyan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/jomfp.JOMFP_88_18","article-title":"The efficiency of propranolol on occurrence and development of 4-nitroquinoline 1-oxide-induced squamous cell carcinoma of the tongue in rats","volume":"24","author":"Cubuk","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/CAD.0b013e32832bd1e3","article-title":"Prevention of pancreatic cancer by the beta-blocker propranolol","volume":"20","author":"Schuller","year":"2009","journal-title":"Anticancer Drugs"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tibensky, M., Cernackova, A., Horvathova, L., Macejova, D., Tillinger, A., and Mravec, B. (2021). Chronic propranolol treatment moderately attenuated development of MNU-induced mammary carcinoma in female rats. Anticancer Drugs, in press.","DOI":"10.1097\/CAD.0000000000001113"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"632","DOI":"10.6002\/ect.2018.0321","article-title":"Effect of Propranolol Treatment on the Incidence of Hepatocellular Carcinoma in Patients Waiting for Liver Transplant With Cirrhosis: A Retrospective, Surveillance Study in a Tertiary Center","volume":"17","author":"Suna","year":"2019","journal-title":"Exp. Clin. Transpl."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/MEG.0000000000000677","article-title":"The use of beta-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis","volume":"28","author":"Herrera","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"577311","DOI":"10.1016\/j.jneuroim.2020.577311","article-title":"Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer","volume":"346","author":"Mravec","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13058-016-0782-5","article-title":"Propranolol and survival from breast cancer: A pooled analysis of European breast cancer cohorts","volume":"18","author":"Cardwell","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/21681805.2018.1559882","article-title":"Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort","volume":"52","author":"Siltari","year":"2018","journal-title":"Scand. J. Urol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijc.30066","article-title":"Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer","volume":"139","author":"Huang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1503\/cmaj.201971","article-title":"Association between antihypertensive medications and risk of skin cancer in people older than 65 years: A population-based study","volume":"193","author":"Drucker","year":"2021","journal-title":"CMAJ"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1470-2045(21)00033-4","article-title":"Antihypertensive treatment and risk of cancer: An individual participant data meta-analysis","volume":"22","author":"Copland","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Cho, I.J., Shin, J.H., Jung, M.H., Kang, C.Y., Hwang, J., Kwon, C.H., Kim, W., Kim, D.H., Lee, C.J., and Kang, S.H. (2021). Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040771"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"44877","DOI":"10.1038\/srep44877","article-title":"Hypertension and breast cancer risk: A systematic review and meta-analysis","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.bjc.6603823","article-title":"Blood pressure and renal cancer risk: The HUNT Study in Norway","volume":"97","author":"Vatten","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","article-title":"Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women","volume":"63","author":"Sanfilippo","year":"2014","journal-title":"Hypertension"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"109437","DOI":"10.1016\/j.mehy.2019.109437","article-title":"Increased cancer risk in polycystic ovary syndrome: An (un)sympathetic connection?","volume":"134","author":"Mravec","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/1940-6207.CAPR-19-0346","article-title":"E-Cigarettes and Cancer Risk","volume":"13","author":"Mravec","year":"2020","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17512433.2020.1788938","article-title":"beta-blocker therapy for infantile hemangioma","volume":"13","author":"Koh","year":"2020","journal-title":"Expert Rev. Clin. Pharm."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1074\/jbc.M611370200","article-title":"Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation","volume":"282","author":"Sastry","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcp.25092","article-title":"Selective beta2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt\/ERK1\/2 Signaling, G1-Phase Arrest, and Apoptosis","volume":"231","author":"Chin","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000054276","article-title":"Suppression of NK cell activity and of resistance to metastasis by stress: A role for adrenal catecholamines and beta-adrenoceptors","volume":"8","author":"Shakhar","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","article-title":"Stress hormone-mediated invasion of ovarian cancer cells","volume":"12","author":"Sood","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_77","first-page":"874","article-title":"Behavioral stress accelerates prostate cancer development in mice","volume":"123","author":"Hassan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.18632\/oncotarget.14119","article-title":"Use of non-selective beta-blockers is associated with decreased tumor proliferative indices in early stage breast cancer","volume":"8","author":"Montoya","year":"2017","journal-title":"Oncotarget"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chang, P.Y., Chung, C.H., Chang, W.C., Lin, C.S., Lin, H.H., Dai, M.S., Ho, C.L., and Chien, W.C. (2019). The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216828"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.24582","article-title":"Beta-blockers improve survival outcomes in patients with multiple myeloma: A retrospective evaluation","volume":"92","author":"Hwa","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: A population- based study","volume":"29","author":"Barron","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12094-016-1608-8","article-title":"Postdiagnostic use of beta-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: An observational study of 10,414 person-years of follow-up","volume":"19","author":"Kim","year":"2017","journal-title":"Clin. Transl. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e172908","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study","volume":"4","author":"Grazzini","year":"2018","journal-title":"Jama Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bj.2019.02.003","article-title":"The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer","volume":"42","author":"Montoya","year":"2019","journal-title":"Biomed. J."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Hopson, M.B., Lee, S., Accordino, M., Trivedi, M., Maurer, M., Crew, K.D., Hershman, D.L., and Kalinsky, K. (2021). Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer. Breast Cancer Res. Treat.","DOI":"10.21203\/rs.3.rs-162839\/v1"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/gerona\/58.1.M82","article-title":"Cancer survivors in the United States: Age, health, and disability","volume":"58","author":"Hewitt","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1037\/a0018836","article-title":"The pain, depression, and fatigue symptom cluster in advanced breast cancer: Covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system","volume":"29","author":"Thornton","year":"2010","journal-title":"Health Psychol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.bbi.2012.03.006","article-title":"Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvement","volume":"30","author":"Neeman","year":"2013","journal-title":"Brain. Behav. Immun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","article-title":"Perioperative events influence cancer recurrence risk after surgery","volume":"15","author":"Hiller","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","article-title":"Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis","volume":"15","author":"Benish","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/SLA.0b013e318211d7b5","article-title":"Improving postoperative immune status and resistance to cancer metastasis: A combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses","volume":"253","author":"Goldfarb","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3892\/or.2016.4710","article-title":"Inhibition of beta2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative beta-blockade","volume":"35","author":"Choy","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5468\/ogs.2017.60.2.170","article-title":"Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study","volume":"60","author":"Jang","year":"2017","journal-title":"Obs. Gynecol. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and beta-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbi.2018.05.014","article-title":"Perioperative inhibition of beta-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome","volume":"73","author":"Haldar","year":"2018","journal-title":"Brain. Behav. Immun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative beta-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1002\/cncr.32950","article-title":"Perioperative COX2 and beta-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial","volume":"126","author":"Haldar","year":"2020","journal-title":"Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","article-title":"Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: Implication in breast cancer treatment","volume":"2","author":"Pasquier","year":"2011","journal-title":"Oncotarget"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-9966-33-21","article-title":"Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model","volume":"33","author":"Deng","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1038\/s41598-020-67342-6","article-title":"The beta-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: A pilot study","volume":"10","author":"Porcelli","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Lucido, C.T., Miskimins, W.K., and Vermeer, P.D. (2018). Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC. Cancers (Basel), 10.","DOI":"10.3390\/cancers10120476"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e1405205","DOI":"10.1080\/2162402X.2017.1405205","article-title":"Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice","volume":"7","author":"Kokolus","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biopha.2018.05.002","article-title":"Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model","volume":"104","author":"Ashrafi","year":"2018","journal-title":"Biomed. Pharm."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Knight, J.M., Kerswill, S.A., Hari, P., Cole, S.W., Logan, B.R., D\u2019Souza, A., Shah, N.N., Horowitz, M.M., Stolley, M.R., and Sloan, E.K. (2018). Repurposing existing medications as cancer therapy: Design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4509-0"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10286-020-00724-y","article-title":"Sympathetic and parasympathetic innervation in cancer: Therapeutic implications","volume":"31","author":"Kamiya","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"250ra115","DOI":"10.1126\/scitranslmed.3009569","article-title":"Denervation suppresses gastric tumorigenesis","volume":"6","author":"Zhao","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41593-019-0430-3","article-title":"Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression","volume":"22","author":"Kamiya","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bph.13662","article-title":"Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice","volume":"174","author":"Maccari","year":"2017","journal-title":"Br. J. Pharm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/1055-9965.EPI-20-1599","article-title":"Beta-Blockers Use and Risk of Breast Cancer in Women with Hypertension","volume":"30","author":"Zheng","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_110","first-page":"779","article-title":"Treatment with beta-blockers and reduced disease progression in patients with thick melanoma","volume":"171","author":"Grazzini","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/s41598-018-25340-9","article-title":"Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression","volume":"8","author":"Brohee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_112","first-page":"495","article-title":"The ABC7 regimen: A new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy","volume":"9","author":"Kast","year":"2017","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cam4.1895","article-title":"\"Not just another meta-analysis\": Sources of heterogeneity in psychosocial treatment effect on cancer survival","volume":"8","author":"Mirosevic","year":"2019","journal-title":"Cancer Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-18-3995","article-title":"Exosomal Induction of Tumor Innervation","volume":"79","author":"Vermeer","year":"2019","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","article-title":"Cancer-related axonogenesis and neurogenesis in prostate cancer","volume":"14","author":"Ayala","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1002\/cncr.26117","article-title":"Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes","volume":"117","author":"Albo","year":"2011","journal-title":"Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41598-020-58425-5","article-title":"Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion","volume":"10","author":"Rowe","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1038\/s41598-021-86831-w","article-title":"Tumor innervation and clinical outcome in pancreatic cancer","volume":"11","author":"Ferdoushi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","article-title":"Progenitors from the central nervous system drive neurogenesis in cancer","volume":"569","author":"Mauffrey","year":"2019","journal-title":"Nature"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/ijc.33138","article-title":"Neuronal signatures in cancer","volume":"147","author":"Jung","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CAD.0b013e3283025b58","article-title":"Neurotransmission and cancer: Implications for prevention and therapy","volume":"19","author":"Schuller","year":"2008","journal-title":"Anticancer Drugs"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trecan.2016.12.008","article-title":"Neuronal Activity in Ontogeny and Oncology","volume":"3","author":"Venkatesh","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajpath.2020.12.006","article-title":"Vascular Endothelial Growth Factor Mediates the Sprouted Axonogenesis of Breast Cancer in Rat","volume":"191","author":"Han","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.ajpath.2014.08.009","article-title":"ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer","volume":"184","author":"Pundavela","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11914-018-0489-x","article-title":"Crosstalk Between Sensory Nerves and Cancer in Bone","volume":"16","author":"Yoneda","year":"2018","journal-title":"Curr. Osteoporos Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41467-018-06640-0","article-title":"Cancer exosomes induce tumor innervation","volume":"9","author":"Madeo","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.humpath.2016.02.001","article-title":"Biologic effect of neurogenesis in pancreatic cancer","volume":"52","author":"He","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pros.23454","article-title":"Influence of the neural microenvironment on prostate cancer","volume":"78","author":"Coarfa","year":"2018","journal-title":"Prostate"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/496159a","article-title":"Drug discovery: A jump-start for electroceuticals","volume":"496","author":"Famm","year":"2013","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/JIR.S163248","article-title":"A review of vagus nerve stimulation as a therapeutic intervention","volume":"11","author":"Johnson","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tips.2020.09.014","article-title":"Electroceuticals in the Gastrointestinal Tract","volume":"41","author":"Ramadi","year":"2020","journal-title":"Trends Pharm. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41575-018-0078-6","article-title":"Bioelectric neuromodulation for gastrointestinal disorders: Effectiveness and mechanisms","volume":"16","author":"Payne","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/acu.2020.1431","article-title":"Electrical Stimulation of PC 6 to Control Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review and Meta-Analysis","volume":"33","author":"Garcia","year":"2021","journal-title":"Med. Acupunct"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.cell.2021.02.034","article-title":"Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer","volume":"184","author":"Levin","year":"2021","journal-title":"Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.isci.2019.11.023","article-title":"Endogenous Bioelectrics in Development, Cancer, and Regeneration: Drugs and Bioelectronic Devices as Electroceuticals for Regenerative Medicine","volume":"22","author":"Levin","year":"2019","journal-title":"iScience"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.2174\/1381612823666170530105837","article-title":"Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer","volume":"23","author":"Tuszynski","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/19336950.2019.1666455","article-title":"Voltage gated sodium channels in cancer and their potential mechanisms of action","volume":"13","author":"Angus","year":"2019","journal-title":"Channels (Austin)"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fphar.2015.00152","article-title":"Voltage-gated sodium channels and cancer: Is excitability their primary role?","volume":"6","author":"Roger","year":"2015","journal-title":"Front. Pharm."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Zheng, Q., Peng, X., and Zhang, Y. (2020). Cytotoxicity of amide-linked local anesthetics on melanoma cells via inhibition of Ras and RhoA signaling independent of sodium channel blockade. BMC Anesth., 20.","DOI":"10.1186\/s12871-020-00957-4"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/jcp.29236","article-title":"Local anesthetics counteract cell proliferation and migration of human triple-negative breast cancer and melanoma cells","volume":"235","author":"Castelli","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00280-019-03815-4","article-title":"Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF\/VEGFR2 signaling","volume":"83","author":"Gao","year":"2019","journal-title":"Cancer Chemother. Pharm."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol. Behav."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10571-018-0631-4","article-title":"Hypothalamic Inflammation at a Crossroad of Somatic Diseases","volume":"39","author":"Mravec","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCO.0000000000000401","article-title":"The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome","volume":"20","author":"Dwarkasing","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Dragano, N.R.V., Solon, C., Ramalho, A.F., de Moura, R.F., Razolli, D.S., Christiansen, E., Azevedo, C., Ulven, T., and Velloso, L.A. (2017). Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation. J. Neuroinflamm., 14.","DOI":"10.1186\/s12974-017-0869-7"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Ropelle, E.R., Flores, M.B., Cintra, D.E., Rocha, G.Z., Pauli, J.R., Morari, J., de Souza, C.T., Moraes, J.C., Prada, P.O., and Guadagnini, D. (2010). IL-6 and IL-10 Anti-Inflammatory Activity Links Exercise to Hypothalamic Insulin and Leptin Sensitivity through IKK beta and ER Stress Inhibition. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000465"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1470-2045(03)01247-6","article-title":"Cancer anorexia: Clinical implications, pathogenesis, and therapeutic strategies","volume":"4","author":"Laviano","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"ref_151","first-page":"1039","article-title":"Effects of aspirin-like drugs on Walker 256 tumor growth and cachexia in rats","volume":"22","author":"Pontieri","year":"1989","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9343(01)00834-8","article-title":"Antipyretics: Mechanisms of action and clinical use in fever suppression","volume":"111","author":"Aronoff","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","article-title":"AMP-activated protein kinase: Maintaining energy homeostasis at the cellular and whole-body levels","volume":"34","author":"Hardie","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: Old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.18632\/aging.100556","article-title":"Metformin, aging and cancer","volume":"5","author":"Moiseeva","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tem.2013.05.004","article-title":"Repositioning metformin for cancer prevention and treatment","volume":"24","author":"Quinn","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"119329","DOI":"10.1016\/j.lfs.2021.119329","article-title":"Investigation into the role of anti-diabetic agents in cachexia associated with metastatic cancer","volume":"274","author":"Bora","year":"2021","journal-title":"Life Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/6115\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:11:26Z","timestamp":1760163086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/6115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,6]]},"references-count":157,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22116115"],"URL":"https:\/\/doi.org\/10.3390\/ijms22116115","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,6]]}}}